Welcome to our dedicated page for Eat Well Investment Group news (Ticker: EWGFF), a resource for investors and traders seeking the latest updates and insights on Eat Well Investment Group stock.
Eat Well Investment Group Inc. (EWGFF) delivers premium plant-based food solutions through brands like Sapientia and Belle Pulses across 35+ countries. This news hub provides investors and industry stakeholders with essential updates about the company’s financial performance, product innovations, and sustainability initiatives.
Discover official press releases covering earnings announcements, strategic partnerships, and operational milestones. Track developments in Eat Well’s core focus areas of agribusiness technology and ESG-aligned food production. All content is verified for accuracy and updated regularly to support informed decision-making.
Key updates include corporate expansions, new product launches, leadership changes, and industry recognitions. Bookmark this page for streamlined access to Eat Well’s evolving role in shaping the future of sustainable nutrition. Check back frequently for the latest developments from this established plant-based food leader.
Eat Well Investment Group Inc. (CNSX:EWG, US:EWGFF) has entered into non-binding term sheets for refinancing credit facilities totaling up to
Eat Well Group, through its subsidiary Belle Pulses, announced strong financial results for Q3 2022, featuring record gross profit of $2,903,217, a 60.3% year-over-year increase. EBITDA rose to $1,978,956, marking a 61.3% increase from the prior year. The company’s total assets also grew by 7.5% to $63,907,968. For 2023, revenue guidance is set between $115MM and $135MM, with adjusted EBITDA expected between $9MM and $14MM. Amara Infant Nutrition reported a 147% increase in revenue, reflecting strong market performance and expansion initiatives.
Belle Pulses reports continued demand and margin expansion, while Amara expands its presence to 100 club stores by year-end. Sapientia aims for 700 outlets by December 2022. The company plans to uplist to the TSX in Q4 2022, with insider ownership exceeding 76%, underscoring confidence in business growth.
Eat Well Investment Group has appointed Dr. Bernhard van Lengerich to its Advisory Board, enhancing its expertise in the plant-based investment sector. With a PhD in Food/Biotechnology and leadership roles at companies like General Mills and Beyond Meat, Dr. van Lengerich will assist in advancing the company's foodtech initiatives. Additionally, Eat Well Group has secured an additional
Eat Well Group's subsidiary, Belle Pulses, reported record financial results for Q2 2022, achieving $15,176,692 in revenue, a 6.8% increase year-over-year. Gross profit soared by 59.6% to $2,032,199, while net earnings surged 295.8% to $1,370,279. These results are attributed to post-COVID market recovery and demand for plant-based foods amid global food security concerns. The company also closed a strategic investment of $5,017,999.50 and resumed its normal course issuer bid for up to 7,686,777 shares.
Eat Well Investment Group has promoted Patrick Dunn to CFO and appointed him to the Board of Directors. Dunn, with a strong background in agribusiness, previously served as Vice President of Finance. His experience includes significant contributions to plant-based food ventures, notably during his tenure with Verdient Foods. The company also expresses gratitude to former CFO Nick Demare for his foundational role since 2014. Eat Well Group continues to focus on high-growth investments in agribusiness and food tech sectors.
